Running time: 56 seconds
Show Full Transcript
This podcast is made possible by the generous support of Lilly Oncology.
Beth Fairchild: My name’s Beth Fairchild, and I’m the president of METAvivor Research and Support. This is the third year that we’ve worked with Eisai for the #ThisIsMBC campaign. The first year featured one patient and we followed them for a year. The second year was Serenity Project, and we focused on the art. And this year we wanted it to be more about the patient and the stories. And so we did an application process, and the patients sent in their story, and — you know, with this disease, we understand what the outcome is going to be, so it’s a really difficult decision-making process to choose. But what we wanted to do was make sure everyone was represented. So we have Black, white, male, female, no matter their education level or socioeconomic background, we wanted to really highlight the fact that this disease does not discriminate. And I think we’ve done that with our model selection this year.
Can we help guide you?
Create a profile for better recommendations
Breast self-exam, or regularly examining your breasts on your own, can be an important way to...
Taking Certain Supplements Before and During Chemotherapy for Breast Cancer May Be Risky
A small study suggests that people who took antioxidant supplements before and during...
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....